OptiNose (Germany) Today
OptiNose is trading at 5.10 as of the 27th of March 2025. This is a 4.67 percent decrease since the beginning of the trading day. The stock's lowest day price was 5.1. OptiNose has reported 15 for 1 split on 2nd of January 2025. The performance scores are derived for the period starting the 27th of December 2024 and ending today, the 27th of March 2025. Click here to learn more.
OptiNose Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. OptiNose's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding OptiNose or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Peter Miller |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
OptiNose (0OP) is traded on Frankfurt Exchange in Germany and employs 189 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 187.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OptiNose's market, we take the total number of its shares issued and multiply it by OptiNose's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. OptiNose classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 111.38 M outstanding shares.
OptiNose has accumulated about 93.92 M in cash with (76.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.76.
Check OptiNose Probability Of Bankruptcy
OptiNose Risk Profiles
Although OptiNose's alpha and beta are two of the key measurements used to evaluate OptiNose's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.81 | |||
| Standard Deviation | 3.99 | |||
| Variance | 15.89 | |||
| Risk Adjusted Performance | (0.02) |
OptiNose Stock Against Markets
OptiNose Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OptiNose stock to make a market-neutral strategy. Peer analysis of OptiNose could also be used in its relative valuation, which is a method of valuing OptiNose by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
OptiNose Corporate Management
Elected by the shareholders, the OptiNose's board of directors comprises two types of representatives: OptiNose inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OptiNose. The board's role is to monitor OptiNose's management team and ensure that shareholders' interests are well served. OptiNose's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OptiNose's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sandra Helton | Independent Director | Profile | |
| Tomas Heyman | Director | Profile | |
| Anthony Krick | VP Officer | Profile | |
| John Messina | Sr Affairs | Profile | |
| Catherine Owen | Director | Profile | |
| Jonathan Neely | VP Operations | Profile |
Additional Information and Resources on Investing in OptiNose Stock
When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock:Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.